𝔖 Bobbio Scriptorium
✦   LIBER   ✦

S-(+)-aporphines are not selective for human D3dopamine receptors

✍ Scribed by Nora S. Kula; Ross J. Baldessarini; John W. Kebabian; John L. Neumeyer

Book ID
105458645
Publisher
Springer
Year
1994
Tongue
English
Weight
528 KB
Volume
14
Category
Article
ISSN
0272-4340

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antiparkinsonian effects of the novel D3
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors
✍ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept